Patent · US Active

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol

US8492557B2 · kind B2 · utility

3Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2011
Grant dateJul 23, 2013
Priority date
Expiry dateSep 15, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/64
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds, ester pro-drugs of [3-(1-1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals in the treatment of conditions mediated by adrenergic receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.